Accelerate the discovery and development of technologies for neglected tropical diseases, malaria and tuberculosis by sharing intellectual property with the global health research community, catalyzing and fostering global health collaborations, and contributing to capacity-building in developing countries.
Short video about the mission of the WIPO Re:Search public-private Consortium
Come Explore IP for a Healthier World: Ten Years of WIPO Re:Search Advancing Global Health (Archived)
A WIPO Virtual Exhibition hosted by the WIPO Knowledge Center that takes a close-up look at how IP and ingenuity fuel an innovative public-private partnership tackling some of the world’s most devastating diseases.
WIPO acts as Secretariat for, and hosts, WIPO Re:Search.
BVGH manages the Partnership Hub, proactively connecting potential users and licensees of WIPO Re:Search and creating research collaborations.
The World Health Organization (WHO) provides WIPO with technical advice on research challenges and opportunities related to NTDs.
The Governance Committee, which comprises all WIPO Re:Search Members, meets annually or biennially. The Committee gives guidance on the general activities and operations of WIPO Re:Search, including its effectiveness at realizing stated aims.
The Advisory Committee provides input and strategic advice for the activities and operations of WIPO Re:Search.
Terms of Reference
WIPO Re:Search continues to deliver on its commitment to bring together the scientific community for the common purpose of facilitating IP sharing in support of research focused on neglected tropical diseases. Pfizer remains a proud member of this initiative and we celebrate the 150+ agreements—and counting—that have been established since its inception.
Eric Aaronson, Senior Vice President & Chief Counsel, Intellectual Property, Pfizer Inc.
Eisai is proud of our engagement in WIPO Re:Search, including drug discovery collaborations with outstanding academic researchers who have been highlighted in publications and presentations by the Consortium leadership. We are honored to be a founding company Member and to share our commitment to improving patients’ quality of life, particularly in low- and middle-income countries, through creation and delivery of innovative medicines.
Dr. Katsura Hata, Senior Director, Global Health Research Section, hhc Data Creation Center, Eisai Co., Ltd.
The WIPO Re:Search platform provides a great network and excellent opportunities for collaborations in the neglected tropical disease space. We have supported this initiative for many years and were able to start new exciting projects, alongside our existing collaborations, through the use of our Mini Library. This open-source approach contributes a lot to addressing Access to Health (A2H) challenges.
Dr. Arno Hartmann, Vice President, Head, Patents Healthcare, Merck KGaA, Darmstadt, Germany
Through WIPO Re:Search, BVGH has connected us with outstanding scientific partners around the world, uniting their expertise and Johnson & Johnson’s resources to catalyze neglected infectious disease R&D with the aim of creating new drugs. Without the Consortium, we would not have had the opportunity to share our Jump-stARter library and other assets so broadly, to potentially develop better solutions for these devastating diseases.
Dr. Paul Jackson, Scientific Director, Johnson & Johnson
Find out more
Our Guiding Principles aim to ensure that all products developed through WIPO Re:Search partnerships will be accessible, royalty-free in all least-developed countries, and licensed in all other places taking into account the level of development of the country and the needs of the patient population.
WIPO has long-term relationships with a number of key donor countries. These donor countries provide Funds-in-Trust (FIT) to finance technical assistance and human capacity building projects to developing counties and countries with economies in transition.
Funds-In-Trust for WIPO Re:Search
The Governments of Australia and of Japan have supported WIPO Re:Search via Funds-In-Trust.